 Once the alleles that correlate with a mutation are characterized, PGH of the embryos is possible and only embryos carrying the low risk haplotypes are selected for transfer.PGH is performed in vitro until this point, when the chosen embryos get placed in the uterus of a surrogate mother for further development.Once a panel of associated genetic markers has been established for a particular disease it can be used for all carriers of that disease.